NewsNewsletter 27 November 2024 Newsletter September 2024 Summary of Newsletter September 2024: Message from President VIPOC Fourth… Marketing 0 Love0
NewsNewsletter 27 November 2024 Newsletter June 2024 Summary of Newsletter June 2024: Message from President World Vitiligo… Marketing 0 Love0
Cairo ConferenceEvents 14 November 2024 How Conferences Strengthen Your Role as a Vitiligo Patient Leader Attending conferences like the VIPOC (Vitiligo International Patient Organization Committee)… Marketing 0 Love0
Newsvitiligo treatment 21 October 2024 Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo News provided by Incyte Biosciences Canada - First and only… Marketing 0 Love0
EADV 2024Events 7 October 2024 EADV Amsterdam 25-28 September 2024 During the EADV conference held in Amsterdam from September 25… Marketing 0 Love0
NewsNon classé 4 October 2024 Opzelura the first drug against vitiligo available in pharmacies The wait was great! The Official Journal of July 23, 2024 has… Marketing 0 Love0
Vitiligo researchVitiligo Scientific Study 6 August 2024 Racial and Ethnic Diversity in Vitiligo Clinical Trials: A Retrospective Cross-Sectional Study Assessing Demographic Reporting of Participants July 2024 | Volume 23 | Issue 7 | e164… Marketing 0 Love0
Member EventsNews 9 July 2024 The Mexican Vitiligo and Skin Disease: Vitiligo A Skin of Colors The Mexican Vitiligo and Skin Disease organisation inaugurated the travelling… Marketing 0 Love0
Member EventsNews 5 July 2024 World Vitiligo Day 2024 Highlights We are thrilled to announce that World Vitiligo Day was… Marketing 0 Love0
News 3 July 2024 Vitiligo recognised as a disease in D.R. Congo The Provincial Minister of Health of Haut-Katanga (Democratic Republic of… Marketing 0 Love0